Optima Health Plc · LSE:OPT
Optima Health — HY26 Earnings Presentation
21 slides from Optima Health's earnings presentation, Dec 10, 2025
Slide 1: HY26 – Financial Results
HY26 – Financial Results 10th December 2025
Slide 2: Agenda
Agenda HY26 Financial Headlines 01 Jonathan Thomas Strategic Progress & Outlook 02 Jonathan Thomas Jonathan Thomas Chief Executive Officer Financial Review 03 Heidi Giles Q&A 04 Open Q&A session Heidi Giles Chief Financial Officer 2 11/12/2025 Optima Health | Commercial in Confidence
Slide 3: Occupational Health & Wellbeing
Occupational Maintenance of Driving positive optimal health workplace wellbeing Health & Wellbeing Maximising performance & Fitness for role attendance The UK’s leading provider by size of technology enabled corporate health and wellbeing solutions Health risk Adaptation of work management & Work Em
Slide 4: Key Fundamental Strengths Enable Optima to Benefit from these Positive Market Dynamics and Capability
Key Fundamental Strengths Enable Optima to Benefit from these Positive Market Dynamics and Capability Integrated ‘Workplace Health’ model delivers Comprehensive holistic range of services Delivery via a flexible, nationwide (UK&I) sector, (OH, Mental Health, MSK, leveraged, digitally- geographic and
Slide 5: HY26 Financial Headlines
HY26 Financial Headlines Jonathan Thomas 5 11/12/2025 Optima Health | Commercial in Confidence
Slide 6: HY26 Financial Headlines
HY26 Financial Headlines HY26: £59.5m (HY25: £50.8m) HY26: £8.3m (HY25: £8.7m) Adjusted Revenue Strong growth over the prior year of 17%, acquisitions Mitigation of cost increase from NI impact; PLC related contributing revenues as planned EBITDA1 costs; ramp up of acquisitions to target profitabili
Slide 7: Strategic Outlook & Progress
Strategic Outlook & Progress Jonathan Thomas 7 11/12/2025 Optima Health | Commercial in Confidence
Slide 8: Target to Grow Business to >£200m Revenue and >£40m EBITDA underpinned by key in-flight Strategic Initiatives
Target to Grow Business to >£200m Revenue and >£40m EBITDA underpinned by key in-flight Strategic Initiatives 4. Overhead 3. M&A Efficiencies • Consolidation • Optimise 2. Operational overhead and of UK market - 1. Organic Transformation buy and build central Medium term progress functions Growth •
Slide 9: Progress and Outlook
Progress and Outlook Progress to Date Plans for next period • Transition well underway of transformational contract delivering • Continuation of transformation programme to scale for medicals to UK Armed Forces in partnership with Serco future growth and deliver a step change in margins – 7-year ini
Slide 10: Financial Review
Financial Review Heidi Giles 10 11/12/2025 Optima Health | Commercial in Confidence
Slide 11: Financials – Statement of Comprehensive Income
Financials – Statement of Comprehensive Income Statement of Comprehensive Income • Revenue – Good progress made with revenue growth of 17% when compared to H1 H1 FY26 H1 FY25 FY25 £m £m £m 25, supported by acquisitions – Underlying organic growth of 3% in contracts over £100k revenue per Revenue 59.
Slide 12: Exceptional Costs
Exceptional Costs Exceptional costs in H1 2026 of £0.6 million Classification of exceptional costs • Acquisition Costs £0.2 million: • Retention of Integration and Change Team to deliver both – External advisor and legal costs relating directly to the new customer transitions and M&A integration act
Slide 13: Financials – Statement of Financial Position
Financials – Statement of Financial Position Statement of Financial Position 30-Sep-25 31-Mar-25 £m £m • Well positioned, stable balance sheet – Net Assets at 30th September 2025 £169.6m compared to £168.1m at Non-Current Assets 189.5 184.1 31st March 2025 Inventories 0.1 0.1 Trade and other receiva
Slide 14: Financials – Cashflow and Net Debt
Financials – Cashflow and Net Debt CASH FLOW and NET DEBT H1 FY26 • Net cash generated from operations £m – Improved by £6.4m compared to £0.1m at H1 FY25 Adjusted EBITDA 8.3 Acquisition, integration and restructuring (0.6) • Working capital movement Working Capital movement (1.3) – £1.9m increase i
Slide 15: Summary and Outlook
Summary and Outlook Jonathan Thomas 15 11/12/2025 Optima Health | Commercial in Confidence
Slide 16: Summary & Outlook
Summary & Outlook UK leader by size in corporate health and wellbeing sector serving public and private sectors Large and growing market with attractive dynamics Strong organic new business momentum - £1.9m ACV won in HY26 + £8.3m won or preferred bidder since the period end – robust pipeline of £11
Slide 17: Q&A
Q&A 17 11/12/2025 Optima Health | Commercial in Confidence
Slide 18: Appendix
Appendix 18 11/12/2025 Optima Health | Commercial in Confidence
Slide 19: ESG
ESG 19 11/12/2025 Optima Health | Commercial in Confidence
Slide 20: Technical Guidance
Technical Guidance • Exceptional costs – Redundant site and IT costs following integration of acquisitions and end of employment costs FY26 Guidance – Small amount of external advice costs for acquisitions completed to date Exceptional costs: Integation costs and employee restructuring £0.8m – Share
Slide 21: Slide 21